First drug found to reduce COVID-19-mortality
According to Principal Investigator Peter Horby from the University of Oxford, the cheap immunomodulatory drug dexamethasone helped reducing...
LSP leads €11m Series A round in OneProject
The financing was led by LSP with Atlantic Bridge University Fund (Ireland) as co-investor, Enterprise Ireland and a selection of prominent...
Polyphor AG bags CHF19.3 in equity financing
Polyphor AG announced it has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to...
BioNTech and Fosun Pharma kick off Chinese COVID-19 trials
In principle, the extended Phase I safety trial will copy a successful safety trial conducted with the modified mRNA COVID-19 vaccine BNT162b1 that...
Bacterial colonisation differs by tumour type
An international research team from Israel, the US, Italy, and the Netherlands profiled the microbiomes of more than 1,500 individual tumours across...
IMI ramps up COVID fund
The European Commission has increased its commitment in IMI from from €45m to €72m stemming from the EU's research and innovation programme Horizon...
Novel adjuvant teases T cells to respond to HCV
In Science Translational Medicine, the team headed by Ilaria Esposito from the University of Rome reports that their novel virally-administered...